Sputnik V vaccine authorized in Armenia

Moscow, February 1, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the Sputnik V vaccine has been approved by the Ministry of Health of the Republic of Armenia. 

The vaccine was approved by a Decree of the Ministry of Health based on data of Phase III clinical trials in Russia without conducting additional trials in Armenia. To date Sputnik V has been registered in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, UAE, Iran, Republic of Guinea and Tunisia.